Encompass Health Corporation
EHC
$112.67
$0.670.60%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.13% | 11.80% | 11.21% | 11.91% | 11.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.13% | 11.80% | 11.21% | 11.91% | 11.15% |
| Cost of Revenue | 8.77% | 9.80% | 9.94% | 11.41% | 11.05% |
| Gross Profit | 14.48% | 14.64% | 13.02% | 12.63% | 11.30% |
| SG&A Expenses | 6.47% | 7.27% | 1.70% | 3.29% | 7.13% |
| Depreciation & Amortization | 9.53% | 12.44% | 10.06% | 9.38% | 9.21% |
| Other Operating Expenses | 12.74% | 11.73% | 11.09% | 10.17% | 9.40% |
| Total Operating Expenses | 9.38% | 10.16% | 9.63% | 10.54% | 10.39% |
| Operating Income | 20.36% | 20.52% | 19.83% | 19.55% | 15.37% |
| Income Before Tax | 25.76% | 27.65% | 26.65% | 23.45% | 20.18% |
| Income Tax Expenses | 16.89% | 15.34% | 10.75% | 13.62% | 18.05% |
| Earnings from Continuing Operations | 28.13% | 30.99% | 31.05% | 26.19% | 20.75% |
| Earnings from Discontinued Operations | 88.03% | 86.18% | 83.74% | 76.67% | -134.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -38.81% | -43.70% | -42.88% | -26.94% | -19.98% |
| Net Income | 28.08% | 30.84% | 31.29% | 29.46% | 19.39% |
| EBIT | 20.36% | 20.52% | 19.83% | 19.55% | 15.37% |
| EBITDA | 17.55% | 18.42% | 17.22% | 16.78% | 13.70% |
| EPS Basic | 27.71% | 30.41% | 30.80% | 28.90% | 18.90% |
| Normalized Basic EPS | 17.22% | 18.25% | 17.22% | 24.04% | 22.37% |
| EPS Diluted | 27.80% | 30.41% | 30.58% | 28.26% | 18.29% |
| Normalized Diluted EPS | 17.64% | 18.51% | 17.22% | 23.45% | 21.71% |
| Average Basic Shares Outstanding | 0.63% | 0.58% | 0.50% | 0.43% | 0.35% |
| Average Diluted Shares Outstanding | 0.29% | 0.42% | 0.57% | 0.91% | 0.89% |
| Dividend Per Share | 12.90% | 13.33% | 10.00% | 6.67% | 3.33% |
| Payout Ratio | -0.11% | -0.16% | -0.19% | -0.20% | -0.16% |